Literature DB >> 11258707

p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes.

E Roper1, W Weinberg, F M Watt, H Land.   

Abstract

In tumorigenesis of the skin, activated Ras co-operates with mutations that inactivate the tumour suppressor p53, but the molecular basis for this co-operation remains unresolved. Here we show that activation of the Raf/MAP kinase pathway in primary mouse keratinocytes leads to a p53 and p21Cip1-dependent cycle arrest and to terminal differentiation. Raf activation in keratinocytes lacking p53 or p21Cip1 genes leads to expression of differentiation markers, but the cells do not cease to proliferate. Thus, loss of p53 or p21Cip1 function is necessary to disable growth-inhibitory Raf/MAP kinase signalling. Activation of oncogenes, including Ras, has been reported to stabilize and activate p53 via induction of the tumour suppressor p19ARF. However, the response to Raf in p19ARFI-/- keratinocytes was indistinguishable from wild-type controls. Thus, p19ARF is not essential for Raf-induced p53 induction and cell cycle arrest in keratinocytes, indicating that oncogenes engage p53 activity via multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258707      PMCID: PMC1083816          DOI: 10.1093/embo-reports/kve020

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  25 in total

Review 1.  Integration of positive and negative growth signals during ras pathway activation in vivo.

Authors:  S Frame; A Balmain
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

Review 2.  The ARF/p53 pathway.

Authors:  C J Sherr; J D Weber
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

3.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Authors:  M Pearson; R Carbone; C Sebastiani; M Cioce; M Fagioli; S Saito; Y Higashimoto; E Appella; S Minucci; P P Pandolfi; P G Pelicci
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

4.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

5.  Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes.

Authors:  E R Li; D M Owens; P Djian; F M Watt
Journal:  Exp Dermatol       Date:  2000-12       Impact factor: 3.960

6.  Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.

Authors:  T Hirakawa; H E Ruley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis.

Authors:  J M Carroll; M R Romero; F M Watt
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

8.  Calcium regulation of growth and differentiation of mouse epidermal cells in culture.

Authors:  H Hennings; D Michael; C Cheng; P Steinert; K Holbrook; S H Yuspa
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

9.  Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals.

Authors:  S H Yuspa; W Vass; E Scolnick
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

10.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue.

Authors:  D R Roop; D R Lowy; P E Tambourin; J Strickland; J R Harper; M Balaschak; E F Spangler; S H Yuspa
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

View more
  15 in total

1.  The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation.

Authors:  Marie C Harrisingh; Elena Perez-Nadales; David B Parkinson; Denise S Malcolm; Anne W Mudge; Alison C Lloyd
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

2.  Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.

Authors:  Mireille J Aleman; Maurice Phil DeYoung; Matthew Tress; Patricia Keating; Gary W Perry; Ramaswamy Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

3.  Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype.

Authors:  Philip J Mitchell; Elena Perez-Nadales; Denise S Malcolm; Alison C Lloyd
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02

6.  Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery.

Authors:  E R Sampson; H R McMurray; D C Hassane; L Newman; P Salzman; C T Jordan; H Land
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

Review 7.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22

8.  Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.

Authors:  Seung-Keun Hong; Seunghee Yoon; Cas Moelling; Dumrongkiet Arthan; Jong-In Park
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

9.  The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.

Authors:  Jong-In Park; Christopher J Strock; Douglas W Ball; Barry D Nelkin
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

10.  Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.

Authors:  Timothy J Bauler; Nobuhiro Kamiya; Philip E Lapinski; Eric Langewisch; Yuji Mishina; John E Wilkinson; Gen-Sheng Feng; Philip D King
Journal:  Dis Model Mech       Date:  2010-11-10       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.